Results 171 to 180 of about 3,724,194 (363)

New Cellular and Molecular Immune Pathways in Ischemia/Reperfusion Injury [PDF]

, 2006
Péter Boros, Jonathan S. Bromberg
openalex   +1 more source

Activation of mosquito complement antiplasmodial response requires cellular immunity

Science immunology, 2017
J. C. Castillo, Ana Beatriz Barletta Ferreira, Nathanie Trisnadi, C. Barillas-Mury   +3 more
semanticscholar   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

The Impact of Hemodialysis on Humoral and Cellular Immunity in Patients with Renal Failure. [PDF]

J Clin Med
Alhamawi RM, Shafea BY, Bakhsh HH, Fayraq LA, Aloufi ST, Alharbi TF, Alharbi AA, Alharbi AA, Alanize BF, Bakhsh AM, Rajih ES, Sandokji IA, Mahallawi WH.   +12 more
europepmc   +1 more source

Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians [PDF]

, 2005
Yi Jiang, Pauline E. Jolly, William O. Ellis, Jia-Sheng Wang, Timothy D. Phillips, Jonathan H. Williams   +5 more
openalex   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Persistent foot-and-mouth disease virus infection of the bovine nasopharynx is associated with suppression of innate and cellular immunity. [PDF]

PLoS One
Litz B, Pfaff F, Forth LF, Hägglund S, Valarcher JF, Beer M, Eschbaumer M.   +6 more
europepmc   +1 more source

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons.

Immunity, 2016
Elizabeth C. Carroll, Lei Jin, A. Mori, Natalia Muñoz‐Wolf, E. Oleszycka, H. Moran, S. Mansouri, Craig P. McEntee, Eimear M Lambe, E. Agger, P. Andersen, C. Cunningham, P. Hertzog, K. Fitzgerald, A. Bowie, E. Lavelle   +15 more
semanticscholar   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Mannose and phenylboronate ester functionalized mesoporous silica nanoparticles contained in chitosan microneedles for enhancing cellular immunity and antitumor efficacy. [PDF]

Theranostics
Chen N, He Y, Zhang Y, Cui Y, Lu H, Zhang J, Zhang H, Zhao Q, Mao Y, Gao Y, Wang S.   +10 more
europepmc   +1 more source